Evidence map›Paper›PMID 42502353›Full record

ArticleClinical, cosmetic and investigational dermatology2026

A Bidirectional Mendelian Randomization Study of Androgenetic Alopecia and Obesity.

Hong Lin, Yuanjun Liu

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hong LinDepartment of Dermatovenereology, Tianjin Medical University General Hospital/Tianjin Institute of Sexually Transmitted Disease, Tianjin, 300052, People's Republic of China.ORCID 0009-0008-6748-7905
Yuanjun LiuDepartment of Dermatovenereology, Tianjin Medical University General Hospital/Tianjin Institute of Sexually Transmitted Disease, Tianjin, 300052, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Androgenetic alopecia (AGA) is a prevalent hereditary hair follicle disorder. Multiple observational epidemiological researches have reported an observational correlation between obesity and AGA onset, whereas reliable evidence supporting their intrinsic causal association is lacking. Methods: Bidirectional two-sample Mendelian randomization (MR) design was performed to explore causal links between obesity and AGA. The inverse variance weighted (IVW) random-effects model was set as the primary causal estimation method, supplemented with weighted median, MR-Egger, simple mode and weighted mode approaches. Multiple sensitivity analyses, including heterogeneity evaluation, horizontal pleiotropy detection and leave-one-out analysis, were conducted to verify result robustness. Results: Forward MR (obesity→AGA) identified no statistically significant causal effect of obesity on AGA risk (IVW OR=1.01, 95% CI 0.98-1.04, P=0.58). Consistently, reverse MR (AGA→obesity) failed to verify a causal influence of AGA on obesity (IVW OR=1.00, 95% CI 0.99-1.01, P=0.83). Subsequent pleiotropy testing and leave-one-out sensitivity analyses yielded concordant outcomes without detectable horizontal pleiotropic bias. Conclusion: This MR analysis excludes bidirectional causal associations between obesity and AGA. Previously observed epidemiological correlations between the two phenotypes are plausibly driven by confounding variables rather than direct causation, providing novel genetic epidemiological evidence for AGA pathogenic exploration.

Indexed as

androgenetic alopeciaGenome-wide association studyMendelian randomizationobesity

Identifiers

PMID42502353
PMCPMC13401371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.